Overview


According to FutureWise analysis the market for Hemostasis (Coagulation) Analyzer in 2023 is US$ 4.52 billion, and is expected to reach US$ 7.15 billion by 2031 at a CAGR of 5.92%.

Testing for blood clotting is used to diagnose problems with the hemostasis system. The medical laboratory assessor known as a coagulometer is used to examine the hemostasis system. The expansion of blood plasma or the presence of blood clots in the blood is detected by new coagulometers using a variety of starting points and observation techniques. The method of assessing the hemostasis system developed approximately fifty years ago has been supported by the majority of coagulometers used in laboratory research. The majority of these techniques are excellent at identifying flaws in one hemostasis component without diagnosing other potential flaws. The thrombosis calculation, or sympathy for the patient's prethrombotic state, is another drawback of the definite hemostasis system evaluator. The growing population base suffering from the syndrome related with standard of living and lifestyle, as well as recurrent blood illnesses, is predicted to contribute to the rising need for coagulation analyzers. Moreover, it is anticipated that growing awareness of these disorders would speed up diagnostic development and preventative care oversight, which is expected to significantly increase testing volume. The emerging nations that are the subject of research and study are currently through an example shift and spending a significant amount of public money to buy and set up such medical technology in their local healthcare facilities. Future trends are expected to include an ageing population, an increase in chronic illnesses, and a rapid growth in foreign investments. The market for hemostasis/coagulation analyzers is anticipated to expand as a result of factors including the rise in cardiovascular illnesses and the ageing population worldwide.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Hemostasis (Coagulation) Analyzer Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Hemostasis (Coagulation) Analyzer Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Alere Inc.
  • Nihon Kohden Corporation
  • Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
  • Siemens Healthcare (A Division of Siemens AG)
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Diagnostica Stago Sas
  • Helena Laboratories
  • Instrumentation Laboratory (A Division of the Werfen Group)
  • International Technidyne Corporation (ITC)

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Clinical Laboratory Analyzers
  • Systems
    • Automated Systems
    • Semi-automated Systems
    • Manual Systems
  • Consumables
    • Reagents
    • Standards, Controls and Calibrations
  • Analyzers for Point-of-Care Testing

By Test

  • Prothrombin Time
  • Fibrinogen
  • Activated Partial Thromboplastin Time
  • Activated Clotting Time
  • D Dimer
  • Platelet Function
  • Anti-factor Xa
  • Heparin
  • Protamine Dose Response Test for ACT
  • Other Coagulation Tests
  • By Technology
  • Mechanical
  • Optical
  • Electrochemical
  • Other Technologies

By End Users

  • Clinical Laboratories
  • POC
  • Others End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Hemostasis (Coagulation) Analyzer Market By Product, By Test, By Technology, By End Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Hemostasis (Coagulation) Analyzer Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Hemostasis (Coagulation) Analyzer Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Hemostasis (Coagulation) Analyzer Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Hemostasis (Coagulation) Analyzer Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Clinical Laboratory Analyzers
        2. Systems
         2.1. Automated Systems
         2.2. Semi-automated Systems
         2.3. Manual Systems
        3. Consumables
         3.1. Reagents
         3.2. Standards, Controls and Calibrations
        4. Analyzers for Point-of-Care Testing

  • 8.   Hemostasis (Coagulation) Analyzer Market, By Test Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prothrombin Time
        2. Fibrinogen
        3. Activated Partial Thromboplastin Time
        4. Activated Clotting Time
        5. D Dimer
        6. Platelet Function
        7. Anti-factor Xa
        8. Heparin and Protamine Dose Response Test for ACT
        9. Other Coagulation Tests

  • 9.   Hemostasis (Coagulation) Analyzer Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Mechanical
        2. Optical
        3. Electrochemical
        4. Other Technologies

  • 10.   Hemostasis (Coagulation) Analyzer Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Clinical Laboratories
        2. POC
        3. Others End Users

  • 11.   North America Hemostasis (Coagulation) Analyzer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Hemostasis (Coagulation) Analyzer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Hemostasis (Coagulation) Analyzer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Hemostasis (Coagulation) Analyzer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Hemostasis (Coagulation) Analyzer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Alere Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Nihon Kohden Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Roche Diagnostics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Siemens Healthcare
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sysmex Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Thermo Fisher Scientific Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Diagnostica Stago Sas
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Helena Laboratories
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Instrumentation Laboratory
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. International Technidyne Corporation (ITC)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients